Yunnan Baiyao Group Co.,Ltd

Shenzhen Stock Exchange 000538.SZ

Yunnan Baiyao Group Co.,Ltd Market Capitalization on January 14, 2025: USD 13.97 B

Yunnan Baiyao Group Co.,Ltd Market Capitalization is USD 13.97 B on January 14, 2025, a 15.89% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Yunnan Baiyao Group Co.,Ltd 52-week high Market Capitalization is USD 15.84 B on October 08, 2024, which is 13.34% above the current Market Capitalization.
Yunnan Baiyao Group Co.,Ltd 52-week low Market Capitalization is USD 11.45 B on February 02, 2024, which is -18.05% below the current Market Capitalization.
Yunnan Baiyao Group Co.,Ltd average Market Capitalization for the last 52 weeks is USD 13.35 B.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

Shenzhen Stock Exchange: 000538.SZ

Yunnan Baiyao Group Co.,Ltd

CEO	Mr. Ming Dong
IPO Date	Dec. 15, 1993
Location	China
Headquarters	No. 3686, Yunnan Baiyao Street
Employees	8,834
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Yunnan Baiyao Group Co.,Ltd engages in the pharmaceutical business in China and internationally. It provides health products, drugs, medical instruments, Chinese medicine resources, and tea. The company offers its products under the Yunnan Baiyao, Yunfeng, Tong Qiaoqiao, Yunjian, Life, Jinkoujian, Langjian, Yangyuanqing, Caizhiji, Baiyao Health, Leopard Seven, Qiancaotang, Qiancao Meizi, and Tianzihong brand names. Yunnan Baiyao Group Co., Ltd. was founded in 1902 and is based in Kunming, China.

Key trends

Past 5 years